Icape Holding (XPAR:ALICA) Research & Development: €0.0 Mil (TTM As of Dec. 2025)


XPAR:ALICA Icape Holding SA XPAR:ALICA
84 GF Score
Price €6.80
GF Value €11.06
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Icape Holding Research & Development?

Icape Holding XPAR:ALICA -0.29% 84 Research & Development is €0.0 Mil as of Dec. 2025. GuruFocus rates XPAR:ALICA with a GF Score™ of 84/100 and a GF Value™ of €11.06 (Possible Value Trap). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Icape Holding's Research & Development for the six months ended in Dec. 2025 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil.


Icape Holding  (XPAR:ALICA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Icape Holding Research & Development Related Terms


Icape Holding Research & Development Historical Data

* Premium members only.

The historical data trend for Icape Holding's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Icape Holding Research & Development Chart

Icape Holding Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Icape Holding Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XPAR:ALICA
84GF Score
Icape Holding SA XPAR:ALICA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Icape Holding Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Icape Holding (XPAR:ALICA) has a Research & Development of €0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Icape Holding and its competitors.
Is Icape Holding's Research & Development too high?
Icape Holding's current Research & Development is €0.0 Mil. Overall, Icape Holding has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Icape Holding's Research & Development compare to APH and GLW?
Icape Holding's Research & Development of €0.0 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Hardware company?
A good Research & Development depends on the Hardware industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Icape Holding and its competitors. Icape Holding's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Icape Holding stock overvalued right now?
Based on GuruFocus' analysis, Icape Holding (XPAR:ALICA) is currently considered Possible Value Trap. The stock's GF Value™ is €11.06, compared to a current price of €6.80 — trading 38.5% below its estimated fair value. The current Research & Development is €0.0 Mil. Icape Holding's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Icape Holding (XPAR:ALICA), the current Research & Development is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Icape Holding (XPAR:ALICA) Overvalued in 2026?

Based on GuruFocus' analysis, Icape Holding stock appears to be undervalued. The current stock price of €6.80 is trading 38.5% below its estimated GF Value™ of €11.06. GuruFocus considers Icape Holding to be Possible Value Trap.

Key valuation signals for XPAR:ALICA:

  • Research & Development: €0.0 Mil
  • GF Value™: €11.06 vs. price of €6.80 (38.5% below fair value)
  • GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the XPAR:ALICA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Icape Holding Business Description

Other Exchanges Z8J:Germany
Address Immeuble Volta 33 Avenue du General Leclerc, Fontenay-aux-Roses, FRA, 92260
Icape Holding SA is engaged in the distribution, trade, and production of printed circuit boards (PCB), which are essential components used across the electronics industry, including the business, telecommunications, automotive, connected objects, home automation, e-mobility, medical, power, multimedia, and IT industries. Its segemnts are: It operates through the Trade in printed circuit boards (PCB) - Americas; Trade and production of printed circuit boards (PCB); Trade and production of printed circuit boards (PCB) - Central Europe; Trade in printed circuit boards (PCB) - Asia and the Rest of the World, which generates maximum revenue; Trade and production of technical parts (Tech Parts) - Europe; and Trade and production of technical parts (Tech Parts) - Rest of the World.
84GF Score

Get the complete analysis for XPAR:ALICA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.80
Price
€11.06
GF Value